indazoles has been researched along with isomethyleugenol in 15 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (6.67) | 18.7374 |
| 1990's | 2 (13.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 9 (60.00) | 24.3611 |
| 2020's | 3 (20.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bruneau, P; Delvare, C; Edwards, MP; McMillan, RM | 1 |
| Bloomquist, W; Cohen, ML; Reid, LR; Robertson, DW; Schenck, K; Wong, DT | 1 |
| Okamoto, HS; Vance, WA; Wang, YY | 1 |
| Allain, CJ; Chesworth, R; Copeland, RA; Jin, L; Keilhack, H; Klaus, CR; Knutson, SK; Kuntz, KW; Majer, CR; Moyer, MP; Olhava, EJ; Pollock, RM; Raimondi, A; Richon, VM; Sacks, JD; Scott, MP; Smith, JJ; Sneeringer, CJ; Song, J; Warholic, NM; Wigle, TJ | 1 |
| Abrams, JS; Conley, BA; Freidlin, B; Korn, EL; McShane, LM; Polley, MY | 1 |
| Cao, JJ; Chen, D; DU, XH; Li, SY; Liu, XH; Ma, JX; Pei, RZ; Sha, KY; Tang, SH; Zhang, PS | 1 |
| Archin, NM; Burch, BD; Margolis, DM; McManamy, ME; Tripathy, MK | 1 |
| Biron, VL; Harris, J; Kostiuk, MA; Lindsay, CD; O'Connell, DA; Seikaly, H | 1 |
| Bulic, M; Dupéré-Richer, D; Ezponda, T; Huang, X; Keats, J; Kelleher, N; Licht, JD; Maji, S; Nabet, B; Occhionorelli, M; Oyer, J; Patel, T; Popovic, R; Riva, A; Shah, MY; Small, EC; Tonon, G; Varghese, N; Will, CM; Zheng, Y | 1 |
| Boblewski, K; Kornicka, A; Lehmann, A; Marchwinska, A; Rybczynska, A; Saczewski, F; Wasilewska, A | 1 |
| Feng, L; Hong, F; Zhang, L; Zhao, M | 1 |
| Huang, J; Huang, S; Li, QJ; Long, H; Symonds, ALJ; Tang, X; Wan, YY; Wang, Z; Xu, L; Zhou, J; Zhu, B | 1 |
| Gildenhuys, S; Magwaza, NM; Mphahlele, MJ; Setshedi, IB | 1 |
| Damle, M; Kim, J; Kingston, RE; Miller, SA | 1 |
| Li, Y; Wang, X; Yan, H; Yin, J; Yu, M | 1 |
15 other study(ies) available for indazoles and isomethyleugenol
| Article | Year |
|---|---|
Indazolinones, a new series of redox-active 5-lipoxygenase inhibitors with built-in selectivity and oral activity.
Topics: Administration, Oral; Animals; Chemical Phenomena; Chemistry; Dinoprostone; Dogs; Humans; Indazoles; Leukotriene B4; Lipoxygenase Inhibitors; Male; Methemoglobinemia; Methylation; Molecular Structure; Oxidation-Reduction; Rats; Rats, Inbred Strains; Stereoisomerism; Structure-Activity Relationship; Thromboxane B2 | 1991 |
Synthesis and biochemical evaluation of tritium-labeled 1-methyl-N-(8-methyl-8-azabicyclo[3.2.1]oct-3-yl)-1H-indazole-3-carboxa mide, a useful radioligand for 5HT3 receptors.
Topics: Animals; Cell Membrane; Cerebral Cortex; Guinea Pigs; Heart Rate; Ileum; Indazoles; Male; Methylation; Myocardium; Rats; Rats, Inbred Strains; Receptors, Serotonin; Serotonin; Serotonin Antagonists; Structure-Activity Relationship; Tritium; Tropanes | 1990 |
Structure-activity relationships of nitro and methyl-nitro derivatives of indoline, indole, indazole and benzimidazole in Salmonella typhimurium.
Topics: Benzimidazoles; Imidazoles; Indazoles; Indoles; Methylation; Mutagenicity Tests; Nitro Compounds; Pyrazoles; Salmonella typhimurium; Structure-Activity Relationship | 1986 |
A selective inhibitor of EZH2 blocks H3K27 methylation and kills mutant lymphoma cells.
Topics: Antineoplastic Agents; Cell Cycle; Cell Death; Cell Proliferation; Dose-Response Relationship, Drug; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Histones; Humans; Indazoles; Lymphoma; Lysine; Methylation; Molecular Structure; Point Mutation; Polycomb Repressive Complex 2; Pyridones; Structure-Activity Relationship | 2012 |
Statistical and practical considerations for clinical evaluation of predictive biomarkers.
Topics: Antineoplastic Agents; Biomarkers, Tumor; Carcinoma, Non-Small-Cell Lung; Carcinoma, Renal Cell; Dacarbazine; DNA Modification Methylases; DNA Repair Enzymes; ErbB Receptors; Gefitinib; Glioblastoma; Humans; Indazoles; Interleukin-6; Kidney Neoplasms; Lung Neoplasms; Methylation; Molecular Targeted Therapy; Mutation; Neoplasms; Precision Medicine; Predictive Value of Tests; Pyrimidines; Quinazolines; Radiotherapy, Adjuvant; Randomized Controlled Trials as Topic; Sample Size; Sulfonamides; Temozolomide; Tumor Suppressor Proteins | 2013 |
[Effects of H3K27 methylation inhibitor EPZ005687 on apoptosis, proliferation and cell cycle of U937 cells and normal CD34 positive cells].
Topics: Antigens, CD34; Apoptosis; Cell Cycle; Cell Proliferation; Humans; Indazoles; Methylation; Pyridones; U937 Cells | 2014 |
H3K27 Demethylation at the Proviral Promoter Sensitizes Latent HIV to the Effects of Vorinostat in Ex Vivo Cultures of Resting CD4+ T Cells.
Topics: Analysis of Variance; CD4-Positive T-Lymphocytes; Chromatin Immunoprecipitation; Enhancer of Zeste Homolog 2 Protein; Enzyme-Linked Immunosorbent Assay; Histones; HIV; Humans; Hydroxamic Acids; Immunoblotting; Indazoles; Methylation; Polycomb Repressive Complex 2; Promoter Regions, Genetic; Proviruses; Pyridones; RNA, Small Interfering; Vorinostat | 2015 |
Efficacy of EZH2 inhibitory drugs in human papillomavirus-positive and human papillomavirus-negative oropharyngeal squamous cell carcinomas.
Topics: Carcinoma, Squamous Cell; Cell Line, Tumor; Cyclin D1; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; ErbB Receptors; Gene Expression Regulation, Neoplastic; Histones; Humans; Indazoles; Methylation; Oropharyngeal Neoplasms; Papillomavirus Infections; Pyridones | 2017 |
UTX/KDM6A Loss Enhances the Malignant Phenotype of Multiple Myeloma and Sensitizes Cells to EZH2 inhibition.
Topics: Animals; Carcinogenesis; Cell Adhesion; Cell Dedifferentiation; Cell Line, Tumor; Cell Proliferation; Cell Survival; Clone Cells; Enhancer of Zeste Homolog 2 Protein; Gene Expression Profiling; Gene Expression Regulation, Neoplastic; Histone Demethylases; Histones; Indazoles; Interferon Regulatory Factors; Lysine; Methylation; Mice; Mice, Inbred NOD; Mice, SCID; Multiple Myeloma; Mutation; Nuclear Proteins; Phenotype; Pyridones; Transcription, Genetic | 2017 |
COMPARISON OF THE EFFECTS OF MARSANIDINE DERIVATIVES ON RAT CARDIOVASCULAR SYSTEM.
Topics: Animals; Antihypertensive Agents; Arterial Pressure; Cardiovascular System; Diuresis; Halogenation; Heart Rate; Imidazolidines; Indazoles; Male; Methylation; Molecular Structure; Rats, Wistar; Structure-Activity Relationship; Time Factors | 2017 |
Inhibition of Ezh2 In Vitro and the Decline of
Topics: Animals; Cell Differentiation; Cells, Cultured; Dopaminergic Neurons; Enhancer of Zeste Homolog 2 Protein; Epigenesis, Genetic; Histone Deacetylase Inhibitors; Histones; Indazoles; Lysine; Mesencephalon; Methylation; Neural Stem Cells; Nuclear Receptor Subfamily 4, Group A, Member 2; Promoter Regions, Genetic; Pyridones; Rats; Rats, Sprague-Dawley; RNA, Small Interfering; Tyrosine 3-Monooxygenase | 2019 |
Targeting EZH2 histone methyltransferase activity alleviates experimental intestinal inflammation.
Topics: Animals; Cell Differentiation; Colitis; Colon; Colonic Neoplasms; Dextran Sulfate; Enhancer of Zeste Homolog 2 Protein; Enzyme Inhibitors; Female; Hematopoietic Stem Cells; Histone Code; Histones; In Vitro Techniques; Indazoles; Indoles; Inflammatory Bowel Diseases; Methylation; Mice; Myeloid-Derived Suppressor Cells; Pyridones | 2019 |
Synthesis, α-glucosidase inhibition and antioxidant activity of the 7-carbo-substituted 5-bromo-3-methylindazoles.
Topics: alpha-Glucosidases; Antioxidants; Glycoside Hydrolase Inhibitors; Halogenation; HEK293 Cells; Humans; Indazoles; MCF-7 Cells; Methylation; Molecular Docking Simulation; Structure-Activity Relationship | 2020 |
Full methylation of H3K27 by PRC2 is dispensable for initial embryoid body formation but required to maintain differentiated cell identity.
Topics: Animals; Cell Differentiation; Cell Line; Embryoid Bodies; Embryonic Stem Cells; Enhancer of Zeste Homolog 2 Protein; Histones; Indazoles; Lysine; Methylation; Mice; Phenotype; Polycomb Repressive Complex 2; Protein Processing, Post-Translational; Pyridones; Transcriptome | 2021 |
Enhanced Calcium Signal Induces NK Cell Degranulation but Inhibits Its Cytotoxic Activity.
Topics: Benzamides; Calcium; Calcium Signaling; Cell Degranulation; Cell Line; Enhancer of Zeste Homolog 2 Protein; Histones; Humans; Indazoles; Killer Cells, Natural; Lymphocyte Activation; Methylation; Piperazines; Pyridones; TRPP Cation Channels | 2022 |